Cancer risk estimation of genotoxic chemicals based on target dose and a multiplicative model

Risk Analysis

Volumn 19, Issue 2, 1999, Pages 309-320

  Granath, Fredrik N ^a,b   Vaca, Carlos E ^a,c   Ehrenberg, Lars G ^a   Törnqvist, Margareta A ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Casco Products AB   (Sweden)

Author keywords

Acrylamide; Butadiene; Cancer risk; Ethylene oxide; In vivo doses; Linear multiplicative model; Relative potency

Indexed keywords

ACRYLAMIDE; ETHYLENE OXIDE; GENOTOXICITY; LINEAR MULTIPLICATIVE MODEL;

BUTADIENE; HEALTH RISKS; MATHEMATICAL MODELS; MUTAGENS; NITROGEN COMPOUNDS; ONCOLOGY; OXIDES; TOXIC MATERIALS; TOXICITY;

RISK ASSESSMENT;

1,3 BUTADIENE; ACRYLAMIDE; ETHYLENE OXIDE DERIVATIVE;

ARTICLE; CANCER RISK; CARCINOGENESIS; DOG; DOSIMETRY; ENVIRONMENTAL PROTECTION; FEMALE; GENOTOXICITY; HUMAN; IONIZING RADIATION; MALE; MODEL; MOUSE; MUTAGENESIS; NONHUMAN; RADIATION DOSE; RAT; RISK ASSESSMENT;

ACRYLAMIDE; ANIMALS; BUTADIENES; DISINFECTANTS; DNA ADDUCTS; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; ETHYLENE OXIDE; FEMALE; HUMANS; INCIDENCE; LINEAR MODELS; MALE; MICE; MODELS, BIOLOGICAL; MUTAGENS; MUTATION; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; NEOPLASMS, RADIATION-INDUCED; RADIATION DOSAGE; RATS; REPRODUCIBILITY OF RESULTS; RISK; RISK ASSESSMENT;

EID: 0032838421     PISSN: 02724332     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006933913194     Document Type: Article

References (51)

1. U.S. Environmental Protection Agency, "Proposed Guidelines for Carcinogen Risk Assessment," (U.S. Environmental Protection Agency, Office of Research and Development, Report No. EPA600/P-92/003C, April, 1996).
2. E. Fearon, and B. Vogelstein, "A genetic model for colorectal tumorigenesis," Cell 61, 759-767 (1990).
3. J. J. McCormick, and V. M. Maher, "Analysis of the multistep process of carcinogenesis using human fibroblasts," Risk Anal. 14, 257-263 (1994).
4. L. Ehrenberg, E. Moustacchi, S. Osterman-Golkar, and G. Ekman, "Dosimetry of genotoxic agents and dose-response relationships of their effects," Mutat. Res. 123, 121-182 (1983).
5. M. Törnqvist, J. Mowrer, S. Jensen, and L. Ehrenberg, "Monitoring of environmental cancer initiators through hemoglobin adducts by a modified Edman degradation method," Anal. Biochem. 154, 255-266 (1986).
6. M. Törnqvist, "Epoxide adducts to N-terminal valine of hemoglobin," in J. Everse, K. D. Vandegriff, and R. M. Winslow, eds, Methods in Enzymology 231, Part B. (Academic Press, New York, 1994), pp. 650-657.
7. M. Törnqvist, and H. Hindsø Landin, "Hemoglobin adducts for in vivo dose monitoring and cancer risk estimation," J. Occup. Environ. Med. 37, 1077-1085 (1995).
8. 14C]ethylene oxide," Arch. Toxicol. 13(suppl), 254-257 (1989).
9. J. B. Storer, T. J. Mitchell, and R. J. M. Fry, "Extrapolation of the relative risk of radiogenic neoplasms across mouse strains and to man," Radiat. Res. 114, 331-353 (1988).
10. UNSCEAR, United Nations Scientific Committee on the Effects of Atomic Radiation, Sources and Effects of Ionizing Radiation, (Report to the General Assembly, United Nations, New York, 1982), pp. 667-670.
11. D. A. Pierce, Y. Shimizu, D. L. Preston, M. Vaeth, and K. Mabuchi, "Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990," Radiat. Res. 146, 1-27 (1996).
12. BEIR V, National Research Council, Committee on the Biological Effects of Ionizing Radiations, Health Effects of Exposure to Low Levels of Ionizing Radiation (National Academy Press, Washington, DC, 1990).
13. ICRP, 1990 Recommendations of the International Commission on Radiological Protection (ICRP Publication 60, Pergamon Press, Oxford, 1991).
14. M. Törnqvist, and L. Ehrenberg, "Risk assessment of urban air pollution," Pharmacogenetics 2, 297-303 (1992).
15. L. Ehrenberg, and G. Scalia-Tomba, "Mathematical models for the initiating and promotive action of carcinogens," in L. Hothorn, ed., Statistical Methods in Toxicology (Lecture Notes in Medical Informatics, Springer, Berlin, 1991), pp. 65-78.
16. L. Ehrenberg, F. Granath, and M. Törnqvist, "Macromolecule adducts as biomarkers of exposure to environmental mutagens in human populations," Environ. Health Perspect. (suppl. 3) 104, 423-428 (1996).
17. B. A. Bridges, "The three-tier approach to mutagenicity screening and the concept of radiation-equivalent dose," Mutat. Res. 26, 335-340 (1974).
18. L. Ehrenberg, K. D. Hiesche, S. Osterman-Golkar, and I. Wennberg, "Evaluation of genetic risks of alkylating agents: Tissue doses in the mouse from air contaminated with ethylene oxide," Mutat. Res. 24, 83-103 (1974).
19. A. C. Andersen, and L. S. Rosenblatt, "The effect of wholebody X-irradiation on the median lifespan of female dogs (beagles)," Radiat. Res. 39, 177-200 (1969).
20. W. M. Snellings, C. S. Weil, and R. R. Maronpot, "A two-year inhalation study of the carcinogenic potential of ethylene oxide in Fischer 344 rats," Toxicol. Appl. Pharmacol. 75, 105-117 (1984).
21. D. W. Lynch, T. R. Lewis, W. J. Moorman, J. R. Burg, D. H. Groth, A. Khan, L. J. Ackerman, and B. Y. Cockrell, "Carcinogenic and toxicologic effects of inhaled ethylene oxide and propylene oxide in F344 Rats," Toxicol. Appl. Pharmacol. 76, 69-84 (1984).
22. 1 Mice (inhalation studies) (Techn. Rep. Ser. No. 326, Research Triangle Park, NC, 1987).
23. K. A. Johnson, S. J. Gorzinski, K. M. Bodner, R. A. Cambell, C. H. Wolf, M. A. Friedman, and R. W. Mast, "Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats," Toxicol. Appl. Pharmacol. 85, 154-168 (1986).
24. M. A. Friedman, L. H. Dulak, and M. A. Stedham, "A lifetime oncogenicity study in rats with acrylamide," Fundam. Appl. Toxicol. 27, 95-105 (1995).
25. 1 Mice (inhalation studies) (Techn. Rep. Ser. No. 434, Research Triangle Park, NC, 1993).
26. A. Nilsen, A.-L. Magnusson, L. Ehrenberg, M. Törnqvist, and F. Granath, "Kinetic aspects of the detoxification of ethylene oxide in mouse inhalation experiments," ms. in preparation (1999).
27. A. D. Tales, et al., "Induction of hprt-mutations in splenic lymphocytes of Lewis rats exposed to ethylene oxide," to be published (1999).
28. F. Granath, L. Ehrenberg, and M. Törnqvist, "Degree of alkylation of macromolecules in vivo from variable exposure," Mutat. Res. 284, 297-306 (1992).
29. D. R. Cox, "Regression models and life-tables (with discussion)," J. Roy. Stat. Soc. 21, 411-421 (1972).
30. P. Rydberg, A.-L. Magnusson, V. Zorcec, F. Granath, and M. Törnqvist, "Hemoglobin adducts for in vivo dosimetry of butadiene metabolites," Chem. Biol. Interact. 101, 193-205 (1996).
31. 14C]acrylamide," Carcinogenesis, 16, 1161-1165 (1995).
32. L. Ehrenberg, and M. Törnqvist, "The research background for risk assessment of ethylene oxide: aspects of dose," Mutat. Res. 330, 41-54 (1995).
33. U.S. Environmental Protection Agency, "Health Assessment Document for Ethylene Oxide-Final Report," (U.S. Environmental Protection Agency, Office of Health and Environmental Assessment, Washington, DC, 1985).
34. D. Hattis, A Pharmacokinetic/Mechanism-based Analysis of the Carcinogenic Risk of Ethylene Oxide, (M.I.T. No. CTPID 87-1, Cambridge, MA, 1987).
35. D. Segerbäck, C. Rönnbäck, P. Bierke, F. Granath, and L. Ehrenberg, "Comparative two-stage cancer tests of ethylene oxide, N-(2-hydroxyethyl)-N-nitrosourea and X-rays," Mutat. Res. 307, 387-393 (1994).
36. A. Kolman, D. Segerbäck, and S. Osterman-Golkar, "Estimalion of the cancer risk of genotoxic chemicals by the radequivalence approach," in H. Bartsch, K. Hemminki and I. K. O'Neill (eds.), Methods for Detecting DNA Damaging Agents in Humans: Applications in Cancer Epidemiology and Prevention, (IARC Sci. Publ. No. 89, Lyon, 1988), pp. 258-264.
37. Y. Shimizu, H. Kato, and W. J. Schull, "Studies of the mortality of A-bomb survivors," Radiat. Res. 121, 120-141 (1990).
38. S. Sasaki, "Influence of the age of mice at exposure to radiation on life-shortening and carcinogenesis," J. Radiat. Res. 32 (suppl 2), 73-85 (1991).
39. R. L. Dedrick, and P. F. Morrison, "Carcinogenic potency of alkylating agents in rodents and humans," Cancer Res. 52, 2464-2467 (1992).
40. L. S. Gold, T. H. Slone, N. B. Manley, G. B. Garfinkel, E. S. Hudes, L. Rohrbach, and B. N. Ames, "The Carcinogenic Potency Database: Analyses of 4000 chronic animal cancer experiments published in the general literature and by the U.S. National Cancer Institute/National Toxicology Program," Environ. Health Perspect. 96, 11-15 (1991).
41. M. Törnqvist, "Current research on hemoglobin adducts and cancer risks: an overview," in C. Travis, ed., Use of Biomarkers in Assessing Health and Environmental Impacts of Chemical Pollutants" (Plenum Press, New York, 1993), pp. 17-30.
42. M. Törnqvist, and A. Kautiainen, "Adducted proteins for identification of endogenous electrophiles," Environ. Health Perspect. 99, 39-44 (1993).
43. F. Burns, R. Alberg, B. Altschuler, and E. Morris, "Approach to risk assessment for genotoxic carcinogens based on data from the mouse skin initiation-promotion model," Environ. Health Perspect. 50, 309-320 (1983).
44. M. Sjögren, L. Ehrenberg, and U. Rannug, "Relevance of different biological assays in assessing initiating and promoting properties of polycyclic aromatic hydrocarbons with respect to carcinogenic potency," Mutat. Res. 358, 97-112 (1996).
45. th Nordic Toxicology Meeting, Abstracts (University of Tampere, Tampere, 1998) p. 185.
46. B. W. Day, S. Naylor, L. S. Gan, Y. Sahali, T. T. Nguyen, P. L. Skipper, J. S. Wishnok, S. Amin, and S. R. Tannenbaum, "Molecular dosimetry of polycyclic aromatic hydrocarbon epoxides and diol epoxides via hemoglobin adducts," Cancer Res. 50, 4611-4618 (1990).
47. H. Helleberg, R. Westerholm, L. Ehrenberg, and M. Törnqvist, "Synthesis and characterisation of N-alkylated L-valine methylamide products from diol epoxide metabolites of fluoranthene and benzo[a]pyrene," Acta Chem. Scand. 52, 797-805 (1998).
48. J. H. Farmer, R. L. Kodell, D. L. Greenman, and G. W. Shaw, "Dose and time responses models for the incidence of bladder and liver neoplasms in mice fed 2-acetylaminofluorene continuously," J. Environ. Pathol. Toxicol. 3 (3 Special no.), 55-68 (1980).
49. M. C. Poirier, and F. A. Beland, "DNA adduct measurements and tumor incidence during chronic carcinogen exposure in rodents," Environ. Health Perspect. 102 (suppl 6), 161-165 (1994).
50. S. H. Moolgavkar, and D. J. Venzon, "Two event model for carcinogenesis: Incidence curves for childhood and adult cancer," Math. Biosci. 47, 55-77 (1979).
51. W. Y. Tan, Stochastic Models of Carcinogenesis (Marcel Dekker, Inc., New York, 1991).